Medical device licence · 70831 · Class 2
RABBIT ANTI-CD3 (T CELL)
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed March 16, 2006; ended November 14, 2018. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 70831
- Licence holder
- Life Technologies CorporationFrederick, MD, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Single Device
- First licensed
- March 16, 2006
- Ended
- November 14, 2018
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- RABBIT ANTI-CD3 (T CELL) 2NDGEN PREDILUTE
- RABBIT ANTI-CD3 (T CELL) CONCENTRATE
- RABBIT ANTI-CD3 (T CELL) PREDILUTE
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.